Institutional investors control 11.23% of the outstanding shares in GSK. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended December 2017, these large investors purchased a net $30.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DODGE & COX Bought 29.2 Million shares of GlaxoSmithKline PLC
ROYAL BANK OF CANADA (CHANNEL IS... Bought 19.2 Million shares of GlaxoSmithKline PLC
TWO SIGMA ADVISERS LP Bought 1.8 Million shares of GlaxoSmithKline PLC